Weekly Protocol

The Wolverine Stack: Why You Load First, Then Maintain

BPC-157 + TB-500 — and the dosing logic behind 1 mg daily for four weeks, then 500 mcg to hold the line.

PepMasteryHealing & Recovery8 min read
The Wolverine Stack — BPC-157 plus TB-500 loading and maintenance dosing

The Wolverine stack — BPC-157 paired with TB-500, named after the Marvel character who heals in seconds — is the most popular recovery combination in the peptide world. Most people get the two ingredients right and the dosing shape wrong. And the shape is the part that actually decides whether it works.

Here's the idea you'll keep coming back to this week: with this stack, the single most important decision isn't which peptide — it's the order of your doses over time. You front-load a heavier month, then drop to a lighter maintenance dose. Run it the other way around, or skip the loading phase, and you spend your first few weeks slowly catching up instead of healing. Let's break down why.

Two peptides, two completely different jobs

BPC-157 — the antenna for healing. It's a 15-amino-acid synthetic peptide derived from a protective protein found in human gastric juice. Its job is to be a local signal. It upregulates VEGFR2 (the receptor that drives new blood-vessel growth), works through the nitric-oxide pathway, and ramps up fibroblasts and collagen organization. In animal studies it accelerates tendon-to-bone and ligament healing. Think of BPC-157 as the antenna planted at the injury that broadcasts one message: build here, and bring blood with you.

TB-500 — the workforce mobilizer. It's a synthetic version of thymosin beta-4, a 43-amino-acid protein your body makes in nearly every cell. Its active fragment is the master regulator of actin — it holds onto roughly 40–50% of a cell's pool of building-block actin and releases it on demand so cells can physically crawl toward damaged tissue. That's cell migration. Unlike BPC-157's local signal, TB-500 works systemically — body-wide.

The core idea

BPC-157 is the signal. TB-500 is the supply line. A signal with no crew — or a crew with no clear signal — heals slowly. The blend gives you both: one says "build here and bring blood," the other sends the construction crew.

Why you load first, then maintain

The answer lives almost entirely in TB-500's biology. Its plasma half-life is short — roughly two to three hours — but its real work (actin remodeling, cell migration, raising tissue levels) plays out over days and depends on reaching a working concentration throughout the body. You're not trying to spike your blood level for a few hours. You're trying to saturate tissue. That's a fundamentally different goal, and it changes how you dose.

Picture filling a reservoir versus topping it off. The loading phase fills the reservoir to the level where the repair machinery runs at full tilt everywhere it's needed. The maintenance phase is the smaller daily trickle that holds that level once it's full. If you skip loading and start at the maintenance dose, you spend the first few weeks slowly filling the reservoir instead of healing — you delay the very results you're paying for.

Loading isn't "more is better." It's "get to the working level fast, then stop overshooting."

That is the whole logic behind four weeks at 1 mg/day, then 500 mcg/day. The first month drives tissue saturation; once you're there, a half-dose is enough to sustain it.

The pre-blend twist most guides get wrong

PepMastery's Wolverine is a pre-blended vial: 5 mg BPC-157 + 5 mg TB-500 in one bottle. That single fact changes the dosing cadence you'll see quoted elsewhere. Standalone TB-500 protocols usually inject only twice a week, because it lingers in tissue. But you can't separate the two peptides inside a blend — so you dose the blend daily, which happens to be exactly the rhythm BPC-157 wants anyway.

That's actually an advantage. BPC-157 gets its ideal once-daily schedule, and TB-500 gets a steady daily drip instead of two big bumps a week — smoother tissue levels, fewer peaks and valleys. Translated into the actual compounds, here's what your blend dose delivers:

PhaseBlend dose (daily)That equals
Loading (weeks 1–4)1 mg500 mcg BPC-157 + 500 mcg TB-500
Maintenance (week 5+)500 mcg250 mcg BPC-157 + 250 mcg TB-500

Over a week, that's about 3.5 mg of TB-500 during loading — squarely in the range research protocols use — dropping to roughly 1.75 mg/week for maintenance. It's the classic "load, then halve" pattern, just delivered as one small shot a day instead of a few large ones.

The exact reconstitution math

Guessing here is how people accidentally take a fraction of their intended dose, decide "peptides don't work," and quit. So let's be precise, using the 10 mg blend vial (5 mg + 5 mg):

StepNumber
Add bacteriostatic water2 mL → concentration of 5 mg/mL
Loading dose (1 mg)0.2 mL = 20 units on a U-100 insulin syringe
Maintenance dose (500 mcg)0.1 mL = 10 units on a U-100 insulin syringe

Both are injected subcutaneously, once daily, ideally around the same time each day. (If your vial size or water volume is different, run your exact numbers through the PepMastery Reconstitution Calculator before you draw — don't eyeball it.)

One practical heads-up on supply: at 1 mg/day, a single 10 mg vial lasts only about ten days. A full four-week loading phase will run through roughly three vials before you ever reach maintenance, so order with that in mind rather than getting caught short mid-load.

What to expect, week by week

Weeks 1–4 (load). Consistency beats heroics here — same dose, same time, every day. Some people notice early shifts in this window (better sleep, a nagging joint quieting down), but real tissue repair is slow biology. Don't judge the stack by week one.

Week 5 onward (maintain). Drop to 500 mcg/day. Most full cycles run six to eight weeks total, then a break. The maintenance dose is designed to hold your gains without continuously overshooting the level you already reached.

The honest part

This load-then-maintain logic is sound and consistent across research protocols — but be clear-eyed about the evidence behind it. The mechanisms are genuinely well-characterized: VEGFR2-driven angiogenesis for BPC-157, actin-driven cell migration for TB-500. The catch is that most of that work comes from animal and cell studies. Human clinical data is thin — only a handful of small pilot studies exist for BPC-157, and TB-500's recovery reputation is largely extrapolated from preclinical research.

Neither peptide is FDA-approved, and both are banned by WADA — so if you're a drug-tested athlete, this stack is disqualifying, full stop. The smart move is to treat the protocol above as an educational framework, not a prescription, and to run anything hormone- or healing-related with a physician who'll actually track how you respond.

Remember this one line

Fill the reservoir for a month, then keep it topped off. Load to start healing fast; maintain to keep it going without waste.

Get next week's protocol in your inbox

Evidence-based peptide breakdowns, every week. No hype — just the research, translated.

Join the PepMastery Newsletter

This content is for educational purposes only and is not medical advice. Many peptides are regulated differently across regions and several are not approved for general human use. Always work with a qualified physician and bloodwork before starting any peptide or hormone-related protocol.